Company: AIP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001667011-25-000022
Chunk: 1

Company: Arteris, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
31, 2025 and December 31, 2024; 41,403,294 and 40,724,936 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively41 40 Additional paid-in capital140,015 135,522 Accumulated other comprehensive income129 135 Accumulated deficit(145,006)(136,885)Total stockholders' deficit(4,821)(1,188)TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT$98,319 $106,135 

See accompanying notes to unaudited condensed consolidated financial statements.

3

Table of Contents

Arteris, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

Three Months EndedMarch 31,20252024RevenueLicensing, support and maintenance$15,335 $11,739 Variable royalties and other1,197 1,208 Total revenue16,532 12,947 Cost of revenue1,526 1,468 Gross profit15,006 11,479 Operating expenses:Research and development11,862 10,835 Sales and marketing6,529 5,456 General and administrative4,323 4,322 Total operating expenses22,714 20,613 Loss from operations(7,708)(9,134)Interest expense(48)(76)Other income (expense), net718 936 Loss before income taxes and loss from equity method investment (7,038)(8,274)Loss from equity method investment, net of tax815 759 Provision for income taxes268 370 Net loss$(8,121)$(9,403)Net loss per share attributable to common stockholders, basic and diluted$(0.20)$(0.25)Weighted average shares used in computing per share amounts, basic and diluted40,853,048 37,709,058 

See accompanying notes to unaudited condensed consolidated financial statements.

4

Table of Contents

 Arteris, Inc.

Condensed Consolidated Statements of Comprehensive Loss

(In thousands)

(Unaudited)

Three Months EndedMarch 31,20252024Net loss$(8,121)$(9,403)Other comprehensive loss:Unrealized losses on available-for-sale securities, net of tax(6)(66)Comprehensive loss$(8